Brothers, Kimberly M.
Stella, Nicholas A.
Shanks, Robert M. Q.
Funding for this research was provided by:
NEI (EY027331, EY08098)
Research to Prevent Blindness (Unrestricted funds)
Eye and Ear Foundation of Pittsburgh (Not applicable)
Article History
Received: 10 January 2020
Accepted: 12 March 2020
First Online: 26 March 2020
Ethics approval and consent to participate
: The use of recombinant DNA materials was approved by the University of Pittsburgh Institutional Biosafety Committee.
: Not applicable.
: Robert MQ Shanks is an Associate Editor of BMC Ophthalmology.